Our website looks best when viewed through a more modern browser such as Google Chrome, Mozilla Firefox, Apple Safari or Microsoft Edge.

If you would like to download one of these browsers, click here.


The Morningside Companies' Proud Past

Origins in Exports

1991 to 2004

  • Founded in 1991
  • Focus on supply to private sector export markets in developing countries
  • Established a reputation for excellence and reliability of supply with NGOs and major UN aid agencies
Morningside Pharmaceuticals Ltd has a rich history

Picture: The Morningside Team at their stand, during an International Exhibition. 

Growth in the UK & Export Markets

2005 to 2012

  • Established a sales & marketing, Quality Assurance and regulatory presence in the UK 
  • First third party contract supply order (2006)
  • Focus on niche, high-value molecules
  • 50+ Marketing Authorisations secured
  • Growing infrastructure with the addition of three distribution centres
  • Building an international and UK distribution network
Morningside Pharmaceuticals Ltd has a rich history

Picture: Morningside customers during an event in Guyana, South America.

Intellectual Property Led Growth

2012 to 2016

  • Morningside wins the Queen’s Award for Innovation: International Trade 2012
  • The Morningside companies establish a Research & Development capability.
  • Completed substantial marketing investment to launch the Headline Brand range
  • Development of supply to NHS hospitals, driving high growth and consistent supply
  • Further investment in infrastructure and new GMP approved buildings

Picture: Morningside’s Distribution Centre, in Loughborough, United Kingdom.

Sector Leading Success

2016 to Today

  • Prime Minister Theresa May hails Morningside as ‘the best of British’ during a trade mission to India (2016)
  • Morningside wins the Innovation in Generics Award at the Pharmacy Business Awards (2017)
  • The Leicester Arena is renamed the Morningside Arena, as part of a major naming-rights deal (2018)
  • Focus on key therapeutic areas 
  • Over 242 generic and branded licensed medicines in the UK and EU
  • Significant opportunity to expand into new global markets
  • Board of Trade Award received from former Secretary of State for International Trade, Dr Liam Fox (2018)
  • Our Chief Executive, Dr Nik Kotecha OBE, was named Entrepreneur of the Year at the 2019 Lloyds Bank National Business Awards and the national Innovation Entrepreneur of the Year at the 2019 Great British Entrepreneur Awards
  • In 2020, as part of the business’ continued expansion, a 5th office and warehousing unit was officially opened at our Loughborough site
  • In 2020 Morningside Pharmaceuticals gained Full Authorised Economic Operator (AEO F) status from HMRC 
  • In 2021 our now Chairman, Dr Nik Kotecha OBE DL, was named a Regional EY Entrepreneur of the Year, as well as one of LDC’s 50 Most Ambitious Business Leaders. In the same year Dr Kotecha also made Medicine Maker magazine’s international Power List. 

This content is intended for Healthcare Professionals, please click the button below to confirm that you are a Healthcare Professional